510(k) Report

510(k) · Cleared

Cleared

EndoflipTM 300

K223705510(k) TraditionalCleared Apr 14, 2023123-day reviewClass II21 CFR 876.1725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Covidien, LLC · FFX System, Gastrointestinal Motility (Electrical)

Cleared on Apr 14, 2023 as substantially equivalent to K183072 (Crospon, Ltd., 2019) after a 123-day review. Its family tree reaches back 5 generations to 1999. 1 later device descends from it.

Decided
Apr 14, 2023
Review
123 days
Class
Class II
Product code
FFX
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K991288 (1999). 6 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 5 generations backK991288 Distender Series II BarostatG & J Electronics, Inc. · 1999
  2. 4 generations backK092850 EndoflipCrospon, Ltd. · 2009
  3. 3 generations backK120997 Barostat Software OptionCrospon, Ltd. · 2012
  4. 2 generations backK160725 EndoFLIPCrospon, Ltd. · 2016
  5. 1 generation backK183072 EndoFLIP SystemCrospon, Ltd. · 2019 · Recalled
  6. This deviceK223705 EndoflipTM 300Covidien, LLC · 2023
  7. Descendant · cites it directly · 0 of its ownK231861 EndoflipTM 300 SystemCovidien, LLC · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K231861EndoflipTM 300 SystemCovidien, LLC · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K991288Distender Series II BarostatG & J Electronics, Inc.1999—
−4K092850EndoflipCrospon, Ltd.2009—
−3K120997Barostat Software OptionCrospon, Ltd.2012—
−2K160725EndoFLIPCrospon, Ltd.2016—
−1K183072EndoFLIP SystemCrospon, Ltd.20191
0 (this device)K223705EndoflipTM 300Covidien, LLC2023—
+1K231861EndoflipTM 300 SystemCovidien, LLC2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K223705, 1999–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FFX device

  1. #1 K262621 Rapid Barostat Bag (RBB) Pump and Catheter…score 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K183072EndoFLIP System
Summary page 4
…725) Regulatory Class: II Product Code: FFX III. PREDICATE DEVICE Predicate Name: EndoflipTM System Predicate 510(k) number: K183072 This submission also used a reference device: Reference Name: FLIP Topography Module Reference 510(k) number:…
Crospon, Ltd.20191
†K170833EndoFLIP® System with FLIP Topography moduleCrospon, Ltd.2017—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231861EndoflipTM 300 SystemCovidien, LLC20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 3.7 years on median.
  • 2 of the 6 ancestors have a recall of any class.
  • Of its descendants, K231861 (Covidien, LLC, 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All FFX devices

FFX System, Gastrointestinal Motility (Electrical): FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · FFX

1in 2025

2007: 22008: 12009: 22010: 22012: 42013: 12016: 32017: 22018: 12019: 42020: 12023: 32024: 12025: 12026 (partial year): 1
2007high 4 (2012) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FFX

123in 2023

2012: 120 days median2016: 145 days median2019: 240 days median2023: 123 days median
2007high 240 (2019) · low 120 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FFX

2so far in 2026, the most since 2007

2009: 12011: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FFX

32in 2025

2009: 22010: 62011: 62012: 42013: 42014: 42015: 102016: 152017: 102018: 172019: 272020: 202021: 262022: 312023: 512024: 592025: 32
2007high 59 (2024) · low 0 (2007)2025

MAUDE reports naming product code FFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
20092—12
20102—06
20110—16
2012412004
20131—04
20140—04
20150—010
20163145015
20172—010
20181—017
20194240027
20201—020
20210—026
20220—031
20233123051
20241—059
20251—032
20261—2—

What is it indicated for?

The Endoflip™ 300 System is indicated for use in a clinical setting to measure pressure and dimensions in the esophagus, pylorus, and anal sphincters in adults and to measure pressure and dimensions in the esophagus, in patients from 5 years of age. It is intended to be used as an adjunct to other diagnostic methods as part of a comprehensive evaluation of patients with symptoms consistent with gastrointestinal motility disorders.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223705: EndoflipTM 300.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223705

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026